Qube Research & Technologies (QRT)
EVMN

Qube Research & Technologies (QRT)’s Evommune Inc EVMN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,057
Closed -$412K – 4266
2025
Q4 		$412K Buy
+24,057
New +$452K ﹤0.01% 2861

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $1.02B AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVMN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Evommune Inc (EVMN) in Q1 2026, closing a stake of 24,057 shares — an estimated $412K sold.

Qube Research & Technologies (QRT) first reported a position in EVMN in Q4 2025 and held it in 1 quarter. The position peaked at $412K in Q4 2025. 84 funds tracked by Wall St. Rank hold EVMN as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Evommune Inc position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24,057 Evommune Inc shares in Q1 2026, an estimated $412K.
  • Qube Research & Technologies (QRT) first reported a position in Evommune Inc in Q4 2025 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Evommune Inc position peaked at $412K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Evommune Inc as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.